2021 PSW Month of Advocacy

How a Pill Becomes a Law / 2021 Law Update

Tuesday, March 2
3 p.m. to 4 p.m.
Kick-off PSW’s Month of Advocacy by learning about the legislative and regulatory process and the different advocacy mechanism offerings that PSW has for getting involved! The second half of the session will focus on recent law and regulation updates, including new vaccination authorities, the updates to Phar 7, and an update on COVID-19 legislation.

Click here to view the PowerPoint slides.

Student Session – Concordia University School of Pharmacy

Monday, March 8
12 p.m. to 1 p.m.
Open only to CUW students, this session will focus on student involvement in advocacy and include roundtables with pharmacy leaders from across Wisconsin. Similar events for MCW and UW students will also be held.

Teaming Up for Better Patient Care: Pharmacist Provider Status

Thursday, March 11
9:30 a.m. to 11 a.m.
Join members of the PSW Provider Status Core Team and Pharmacy Advancement Leadership Team (PALT) in learning about provider status efforts in Wisconsin. Then, break into small-group discussions to discuss potential benefits, barriers, and strategies to implement pharmacist billing for services.

Student Session – UW-Madison School of Pharmacy

Tuesday, March 16
4:30 p.m. to 5:30 p.m.
Open only to UW students, this session will focus on student involvement in advocacy and include roundtables with pharmacy leaders from across Wisconsin. Similar events for CUW and MCW students will also be held.

COVID-19 and Beyond: An Update from Governor Tony Evers

Thursday, March 25
8 a.m. to 8:30 a.m.
Join Wisconsin’s Governor, Tony Evers, for an update on the state’s vaccine rollout, COVID-19 response, and other healthcare priorities in his second biennial budget. Please note, time and date are subject to change per the Governor’s availability.

Redesigning Pharmacy Benefits: PBMs, Transparency & Competitive Markets

Thursday, March 30
12 p.m. to 1 p.m.
How can we establish transparency, competitive markers, open access, AND keep patients at the center of their care throughout the entire prescription drug supply chain? Join 46brooklyn co-founder, APhA Senior Advisor for Disruptive Innovation and Practice Transformation, and nationally-renowned pharmacy benefits expert Antonio Ciaccia for a conversation about the future of pharmacy benefits.

Legislative Panel: Current Issues in Healthcare Policy

Friday, March 5
12 p.m. to 1 p.m.
COVID-19, Medicaid Expansion, scope of practice changes, payment for services – what’s on the agenda of legislative healthcare leaders in Wisconsin for 2021? Join Republican and Democrat leaders of the legislature’s health committees to discuss their priorities.

Student Session – Medical College of Wisconsin School of Pharmacy

Wednesday, March 10
1 p.m. to 1:50 p.m.
Open only to MCW students, this session will focus on student involvement in advocacy and include roundtables with pharmacy leaders from across Wisconsin. Similar events for CUW and UW students will also be held.

COVID-19: A Comprehensive Look at Pharmacy’s Role in the Pandemic

Monday, March 15
12 p.m. to 1 p.m.
COVID-19 has been unprecedented in countless ways – including the collaboration between state, local, federal, health-system and community-based providers. Hear from infectious disease, regulatory, and public health experts on current issues relating to the pandemic, including vaccination, testing, contact tracing, and more.

Pharmacy Examining Board Update

Wednesday, March 17
11 a.m. to 12 p.m.
From rule updates to pandemic variances, tune in for an update on the Pharmacy Examining Board (PEB)’s recent and upcoming work.

An Update on the FDA Compounding Memorandum of Understanding

Tuesday, March 23
3 p.m. to 4 p.m.
Since its release in late 2020, the FDA’s Memorandum of Understanding with states on interstate shipments of compounding medications has been subject to concerns from compounding pharmacies and state Boards of Pharmacies. The decision of whether or not to sign the MOU has forced states to make a no-win decision: if they sign the MOU, the state board of pharmacy must assume a significant – and unfunded – administrative burden. If the state doesn’t sign, compounding pharmacies will be restricted to shipping out-of-state no more than five percent of all compounded medications they dispense (including patient-specific meds) – limiting patient access to compounded meds and may lead to pharmacy closings. Join leaders from the Alliance for Pharmacy Compounding, who are spearheading efforts to address the flaws of the MOU, for a briefing about what the MOU will mean for your pharmacy and the patients you serve – as well as what APC is doing to combat it.